These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25124967)

  • 1. The FGF-1-specific single-chain antibody scFv1C9 effectively inhibits breast cancer tumour growth and metastasis.
    Shi H; Fu C; Wang W; Li Y; Du S; Cao R; Chen J; Sun D; Zhang Z; Wang X; Zhu X
    J Cell Mol Med; 2014 Oct; 18(10):2061-70. PubMed ID: 25124967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel single-chain variable fragment antibody against FGF-1 inhibits the growth of breast carcinoma cells by blocking the intracrine pathway of FGF-1.
    Shi HL; Yang T; Deffar K; Dong CG; Liu JY; Fu CL; Zheng DX; Qin B; Wang JJ; Wang XZ; Zhu XJ
    IUBMB Life; 2011 Feb; 63(2):129-37. PubMed ID: 21360642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of penta-O-galloyl-β-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.
    Lee HJ; Seo NJ; Jeong SJ; Park Y; Jung DB; Koh W; Lee HJ; Lee EO; Ahn KS; Ahn KS; Lü J; Kim SH
    Carcinogenesis; 2011 Jun; 32(6):804-11. PubMed ID: 21289371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipyridamole prevents triple-negative breast-cancer progression.
    Spano D; Marshall JC; Marino N; De Martino D; Romano A; Scoppettuolo MN; Bello AM; Di Dato V; Navas L; De Vita G; Medaglia C; Steeg PS; Zollo M
    Clin Exp Metastasis; 2013 Jan; 30(1):47-68. PubMed ID: 22760522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrophobic poly (amino acid)-modified PEI-mediated delivery of single-chain antibody scFv1C9 inhibits HepG2 cell cycle process and xenograft growth in nude mice.
    Fu C; Zheng D; Shi H; Tian H; Zhu X; Chen X
    J Biomater Sci Polym Ed; 2014; 25(9):872-80. PubMed ID: 24754301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts.
    Hegab AE; Ozaki M; Kameyama N; Gao J; Kagawa S; Yasuda H; Soejima K; Yin Y; Guzy RD; Nakamura Y; Ornitz DM; Betsuyaku T
    J Pathol; 2019 Oct; 249(2):193-205. PubMed ID: 31090071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tiamulin inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of CD73.
    Yang X; Pei S; Wang H; Jin Y; Yu F; Zhou B; Zhang H; Zhang D; Lin D
    BMC Cancer; 2017 Apr; 17(1):255. PubMed ID: 28399915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HYAL1 overexpression is correlated with the malignant behavior of human breast cancer.
    Tan JX; Wang XY; Li HY; Su XL; Wang L; Ran L; Zheng K; Ren GS
    Int J Cancer; 2011 Mar; 128(6):1303-15. PubMed ID: 20473947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting metastatic breast cancer with peptide epitopes derived from autocatalytic loop of Prss14/ST14 membrane serine protease and with monoclonal antibodies.
    Kim KY; Yoon M; Cho Y; Lee KH; Park S; Lee SR; Choi SY; Lee D; Yang C; Cho EH; Jeon SD; Kim SH; Kim C; Kim MG
    J Exp Clin Cancer Res; 2019 Aug; 38(1):363. PubMed ID: 31426843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
    Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic morphogen nodal promotes breast cancer growth and progression.
    Quail DF; Zhang G; Walsh LA; Siegers GM; Dieters-Castator DZ; Findlay SD; Broughton H; Putman DM; Hess DA; Postovit LM
    PLoS One; 2012; 7(11):e48237. PubMed ID: 23144858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of vasopressin synthetic analogue [V(4)Q(5)]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models.
    Garona J; Pifano M; Pastrian MB; Gomez DE; Ripoll GV; Alonso DF
    Clin Exp Metastasis; 2016 Aug; 33(6):589-600. PubMed ID: 27146156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of EGFR pathway signaling and the metastatic potential of breast cancer cells by PA-MSHA mediated by type 1 fimbriae via a mannose-dependent manner.
    Liu ZB; Hou YF; Zhu J; Hu DL; Jin W; Ou ZL; Di GH; Wu J; Shen ZZ; Shao ZM
    Oncogene; 2010 May; 29(20):2996-3009. PubMed ID: 20228837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase.
    Bartholomeusz C; Gonzalez-Angulo AM; Kazansky A; Krishnamurthy S; Liu P; Yuan LX; Yamasaki F; Liu S; Hayashi N; Zhang D; Esteva FJ; Hortobagyi GN; Ueno NT
    Clin Cancer Res; 2010 Mar; 16(6):1802-11. PubMed ID: 20215547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death.
    Nilsson EM; Brokken LJ; Härkönen PL
    Exp Cell Res; 2010 Mar; 316(5):800-12. PubMed ID: 19962979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capillary morphogenesis gene 2 inhibits growth of breast cancer cells and is inversely correlated with the disease progression and prognosis.
    Ye L; Sun PH; Malik MF; Mason MD; Jiang WG
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):957-67. PubMed ID: 24667935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin.
    Zhang N; Wang X; Huo Q; Sun M; Cai C; Liu Z; Hu G; Yang Q
    Oncogene; 2014 Jun; 33(24):3119-28. PubMed ID: 23851509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs.
    Jia X; Yu F; Wang J; Iwanowycz S; Saaoud F; Wang Y; Hu J; Wang Q; Fan D
    Breast Cancer Res Treat; 2014 Nov; 148(2):291-302. PubMed ID: 25311112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
    Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
    Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ER81-shRNA inhibits growth of triple-negative human breast cancer cell line MDA-MB-231 in vivo and in vitro.
    Chen Y; Zou H; Yang LY; Li Y; Wang L; Hao Y; Yang JL
    Asian Pac J Cancer Prev; 2012; 13(5):2385-92. PubMed ID: 22901226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.